Retrospective Study
Copyright ©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 571-583
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.571
Table 1 Clinical and histological characteristics of the patient population (n = 489)
Characteristics
Values
Age50.1 (14-82)
Male sex, %54.6
Body mass index, kg/m226.9 (20.8-49.5)
Fibrosis stage, 0/1/2/3/465/173/111/122/18
Grade, 0/1/2/345/204/178/62
Steatosis, 0/1/2/313/158/228/90
NAFLD activity score, < 4/≥ 5265/224
ALT, IU/L69 (2-563)
AST, IU/L43 (13-312)
γ-GTP, IU/L60 (12-736)
Total bilirubin, mg/dL0.8 (0.04-2.7)
Total cholesterol, ng/dL198 (102-317)
Cholinesterase, IU/L205 (90-337)
Platelet count, × 104/μL20.8 (6.6-44.7)
Albumin, g/dL4.5 (2.5-5.4)
HOMA-IR2.9 (0.7-22.4)
Iron, μg/dL119 (13-295)
Ferritin, ng/dL149 (3.9-983)
Leptin, ng/dL9.3 (1.1-59.3)
Adiponectin, μg/mL5.5 (2.0-27.5)
High-sensitivity CRP, mg/dL0.117 (0.01-1.92)
P-III-P, U/mL0.7 (0.28-3.8)
Type IV collagen 7S, ng/mL4.1 (1.9-15)
Hyaluronic acid, ng/mL28 (9-619)
Fibrosis-4 index1.29 (0.17-1.29)
Table 2 Summary of the causes of death

n (%)
All deaths13 (2.7)
Liver-related events7 (1.4)
HCC + liver failure3
HCC only1
Liver failure3
Cerebrovascular disease1 (0.2)
Non-liver cancers4 (0.8)
Pancreatic cancer2
Bile duct cancer2
Infection1 (0.2)
Table 3 Factors associated with mortality among the patients with non-alcoholic fatty liver disease (n = 489)

AUROC
Odds ratio
95%CI
P value
AST0.571.000.99-1.020.9841
ALT0.710.970.95-0.990.0026
γ-GTP0.5211.000.99-1.010.4259
Platelet count0.7480.780.69-0.88< 0.0001
Total bilirubin0.5881.100.55-1.390.3208
Total cholesterol0.5800.990.98-1.010.2
Iron0.5531.011.020.1801
Albumin0.8150.0930.04-0.20< 0.0001
Ferritin0.5271.001.00-1.000.7651
Leptin0.5651.000.94-1.060.7441
HOMA-IR0.7311.041.009-1.060.0182
P-III-P0.7865.582.27-11.60.0014
Type IV collagen 7S0.8631.481.28-1.67< 0.0001
Fibrosis-4 index0.9141.7991.44-2.23< 0.0001